Penserra Capital Management’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Penserra Capital Management’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-30,602	Closed	-$91K	–	1563
2022 Q1	$91K	Buy	30,602 +15,529	+103%	+$34.2K	﹤0.01%	870
2021 Q4	$19K	Buy	15,073 +6,428	+74%	+$12.9K	﹤0.01%	1241
2021 Q3	$19K	Buy	8,645 +643	+8%	+$2.31K	﹤0.01%	1258
2021 Q2	$45K	Sell	8,002 -5,009	-38%	-$33.3K	﹤0.01%	1031
2021 Q1	$81K	Sell	13,011 -3,280	-20%	-$24.6K	﹤0.01%	725
2020 Q4	$127K	Buy	+16,291	New	+$144K	﹤0.01%	588

Penserra Capital Management's TLMD Position: Q2 2022 in Review

Penserra Capital Management sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 30,602 shares — an estimated $91K sold.

Penserra Capital Management first reported a position in TLMD in Q4 2020 and held it in 6 quarters. The position peaked at $127K in Q4 2020. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Penserra Capital Management reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Penserra Capital Management sold 30,602 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $91K.
Penserra Capital Management first reported a position in SOC Telemed, Inc. Class A Common Stock in Q4 2020 and held it in 6 quarters.
Penserra Capital Management's SOC Telemed, Inc. Class A Common Stock position peaked at $127K in Q4 2020.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Penserra Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.